| CUSIP No. 019770 10 6 | 13G | Page 9 of 9 Pages |
Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common stock of Allogene Therapeutics, Inc., a Delaware corporation, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts all of which, taken together, shall constitute one and the same instrument.
Dated: February 14, 2024
| /s/ David Chang |
David Chang, M.D., Ph.D. |
Chang 2006 Family Trust | ||
| By: | /s/ David Chang | |
| Name: | David Chang, Co-Trustee | |
JEC 2019 Trust | ||
| By: | /s/ David Chang | |
| Name: | David Chang, Co-Trustee | |
RTC 2019 Trust | ||
| By: | /s/ David Chang | |
| Name: | David Chang, Co-Trustee | |
